These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 24199318)

  • 1. Researchers solve high-resolution structure of HIV co-receptor CCR5.
    von Bubnoff A
    IAVI Rep; 2013; 17(3):15. PubMed ID: 24199318
    [No Abstract]   [Full Text] [Related]  

  • 2. A functionally selective synthetic mimic of the HIV-1 co-receptor CXCR4.
    Möbius K; Dürr R; Haussner C; Dietrich U; Eichler J
    Chemistry; 2012 Jul; 18(27):8292-5. PubMed ID: 22692798
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on CCR5 analogs and affinity peptides.
    Wu Y; Deng R; Wu W
    Protein Eng Des Sel; 2012 Mar; 25(3):97-105. PubMed ID: 22238429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building three-dimensional structures of HIV-1 coreceptor CCR5 and its interaction with antagonist TAK779 by comparative molecular modeling.
    Huang XQ; Jiang HL; Luo XM; Chen KX; Ji RY; Cao Y; Pei G
    Acta Pharmacol Sin; 2000 Jun; 21(6):521-8. PubMed ID: 11360686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of HIV-1 coreceptor CCR5 and exploring of conformational space of its extracellular domain in molecular dynamics simulation.
    Efremov RG; Legret F; Vergoten G; Capron A; Bahr GM; Arseniev AS
    J Biomol Struct Dyn; 1998 Aug; 16(1):77-90. PubMed ID: 9745897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the structural basis of human CCR5 chemokine receptor function: from homology model building and molecular dynamics validation to agonist and antagonist docking.
    Fano A; Ritchie DW; Carrieri A
    J Chem Inf Model; 2006; 46(3):1223-35. PubMed ID: 16711742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
    Zhou N; Luo Z; Hall JW; Luo J; Han X; Huang Z
    Eur J Immunol; 2000 Jan; 30(1):164-73. PubMed ID: 10602038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 coreceptor selectivity: structural analogy between HIV-1 V3 regions and chemokine beta-hairpins is not the explanation.
    Scheib H; Sperisen P; Hartley O
    Structure; 2006 Apr; 14(4):645-7; discussion 649-51. PubMed ID: 16615905
    [No Abstract]   [Full Text] [Related]  

  • 12. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.
    Mirzabekov T; Kontos H; Farzan M; Marasco W; Sodroski J
    Nat Biotechnol; 2000 Jun; 18(6):649-54. PubMed ID: 10835604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
    Yang J; Liu CQ
    Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the CCR5 extracellular pocket.
    Pérez-Nueno VI; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Nov; 48(11):2146-65. PubMed ID: 18942828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers.
    Yoshiura C; Kofuku Y; Ueda T; Mase Y; Yokogawa M; Osawa M; Terashima Y; Matsushima K; Shimada I
    J Am Chem Soc; 2010 May; 132(19):6768-77. PubMed ID: 20423099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.
    Isik N; Hereld D; Jin T
    PLoS One; 2008; 3(10):e3424. PubMed ID: 18923649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical studies on the interactions and interferences of HIV-1 glycoprotein gp120 and its coreceptor CCR5.
    Da LT; Wu YD
    J Chem Inf Model; 2011 Feb; 51(2):359-69. PubMed ID: 21284403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
    Kellenberger E; Springael JY; Parmentier M; Hachet-Haas M; Galzi JL; Rognan D
    J Med Chem; 2007 Mar; 50(6):1294-303. PubMed ID: 17311371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.